ADHD in Adults: What the Evidence Says and What Myths Down

Every 13 of July is commemorated on the International Day of ADHD, and it is a good excuse to do something that the date usually deserves less than it receives: to separate what the evidence says from the disorder from what is repeated about it. Because few conditions accumulate so many myths in opposite directions: that "it does not exist", that "it is an invention of the industry", that "heals only by growing" or, at the other end, that any daily distraction confirms it.

For psychologists working with adolescents and adults, ADHD poses a specific clinical challenge: it is frequent, it is subdiagnosed in adults, it rarely comes alone and its course is less linear than the manuals suggested. Let’s see what the research says.

TL;DR

• ADHD affects about 5.9% of children and adolescents and 2.5-2.8% of adults globally.
• In adults, the gap between symptoms present and clinical diagnosis is strongly underdiagnosed:, especially after 50 years.
• The idea that "half overcomes it as they grow" became old: the typical course is fluctuating, with remission and recurrence periods. Only ~9% shows sustained recovery.
• Adult ADHD CCT shows moderate effects on symptoms and functioning compared to control conditions.

Why it Matters

If you care for adults, it is almost certain that patients with undiagnosed ADHD have already gone through your clinical practice. Many come for something else: depression, anxiety, partner problems, "chronic disorganization", erratic performance history. Adult ADHD rarely presents itself as such; it is presented as its consequences.

And the cost of not seeing it is real: years of treatments that point to comorbidity without touching the base factor, and patients who carry narratives of "vagance" or "lack of will" that a correct diagnosis could have disarmed long before.

What the evidence says

It is common, also in adults

The reference document today is the International Consensus of the World Federation of ADHD (Faraone et al., 2021): 208 evidence-based conclusions, signed by 80 authors from 27 countries, built only on large studies (more than 2.000 participants) or meta-analysis. According to consensus, 5.9% of young people and 2.5-2.8% of adults meet diagnostic criteria.

The overall meta-analysis of Song et al. (2021) adds an important nuance: the prevalence of persistent ADHD in adults (with a documented onset in childhood) was 2.58%, but that of symptomatic ADHD (symptoms present in adulthood, without requiring confirmation of childhood onset) was 6,76%. Translated: hundreds of millions of adults in the world with clinically relevant symptoms, most without diagnosis.

Subdiagnosis in adults is massive

The consensus itself quantifies it in its most extreme range: in people over 50 years, the clinical diagnosis rate recorded is just 0.2%, against a much greater symptomatic prevalence measured with scales. The gap between what exists and what is diagnosed is widening with age.

"It heals when it grows" is more myth than fact

For years it was repeated that about half of the children with ADHD "surpassed" when they reached adulthood. Following the MTA study (Sibley et al., 2022), published in the American Journal of Psychiatry, complicated that image: the most frequent pattern was neither stable persistence nor recovery, but fluctuation. 63.8% of the participants alternated periods of remission and recurrence over time. Only 9.1% showed sustained recovery until the end of the study, and about 90% continued to present residual symptoms in young adulthood.

The clinical implication is direct: that a patient is "well" today does not close the chapter. ADHD is more like a condition that fluctuates with the context and demands of each life stage than with something that has or is no longer present.

Psychological therapy provides, and is measurable

Treatment of adult ADHD is not only pharmacological. The meta-analysis of Knouse, Teller and Brooks (2017), about 32 cognitive-behavioral treatment studies for adult ADHD, found effects compared to control conditions of g = 0.65 for self-reported symptoms and g = 0.51 for functioning. They are moderate effects, in line with what psychotherapy achieves in other tables, on very specific skills: organization, planning, time management, emotional regulation.

What the evidence DOES NOT say

• It does not say that any distraction is ADHD. The diagnosis requires a persistent pattern, with functional deterioration, in more than one context. The popularization of the term (and its viralization in networks) does not change the criteria.
• It does not say it is an invention. The conclusion of the international consensus is exactly the opposite: few psychological conditions have such a broad and replicated empirical basis on their existence, course and treatment.
• Does not say adult diagnosis is trivial. Evaluating adult ADHD is genuinely difficult: it requires evolutionary history, discarding and weighting comorbidities (depression, anxiety, consumption, bipolarity, according to consensus the most frequent) and distinguishing ADHD symptoms from those of those same tables.

What does it mean in your clinical practice

• I included ADHD in your adult differential radar. When you consult for chronic disorganization, erratic academic or work history, persistent "procrastination" or anxiety/depression treatments that progress less than expected, ask if there is an unevaluated basic ADHD.
• Ask for history, not just for the present. Adult ADHD is evaluated backwards: school performance, newsletters, what teachers said, what it was like to organize 10 years. Documenting well that timeline is half the evaluation.
• Waits for fluctuation, not linearity. If the typical course alternates referrals and recurrences, setbacks in times of higher demand (ascent, parenthood, a move) are expected part of the picture, not a failure of the treatment. Anticipating it with the patient protects the alliance and reduces the risk of abandoning.
• Work with concrete and measurable objectives. Treatments that show effect are those that point to specific abilities. This lends itself especially well to monitoring results: define with the patient what they will consider improvement and review it systematically.

Killings and limitations

• Prevalence figures depend on method. The difference between 2,58% and 6,76% in Song et al. is not a contradiction: it reflects different definitions (persistent vs. symptomatic). Any number of adult ADHD you read comes with that small letter.
• The MTA followed children diagnosed in the 1990s. Their findings on the fluctuating course are solid, but describe a specific cohort, treated in a specific health system.
• The effects of CCT are mainly based on self-reporting. The effect sizes of Knouse et al. are smaller when reporting external observers, a common pattern in psychotherapy that should be borne in mind.
• None of this replaces individual clinical evaluation. Population evidence guides; diagnosis is done by a professional on a case-by-case basis.

In summary

The evidence about adult ADHD draws a clear picture: it is common, it is subdiagnosed, almost never comes alone, fluctuates throughout life and responds to structured psychological treatment. For the clinical psychologist, the International Day of ADHD is less an event than a reminder: behind many consultations for "other thing" there is a basic attention pattern that no one has yet looked at.

And if something asks for the work with these patients is orderly documentation: the evolutionary history, the concrete objectives, the agreements of each session. In that a tool like Brauni can help you keep the record structured and up-to-date; the clinical look that detects the pattern, that is still yours.

References

• Faraone, S. V., Banaschewski, T., Coghill, D., et al. (2021). The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder. Neuroscience & Biobehavioral Reviews, 128, 789-818. https://doi.org/10.1016/j.neubiorev.2021.01.022
• Song, P., Zha, M., Yang, Q., Zhang, Y., Li, X., & Rudan, I. (2021). The prevalence of adult attention-deficit hyperactivity disorder: A global systematic review and meta-analysis. Journal of Global Health, 11, 04009. https://doi.org/10.7189/jogh.11.04009
• Sibley, M. H., Arnold, L. E., Swanson, J. M., et al. (2022). Variable Patterns of Remission From ADHD in the Multimodal Treatment Study of ADHD. American Journal of Psychiatry, 179(2), 142-151. https://doi.org/10.1176/appi.ajp.2021.21010032
• Knouse, L. E., Teller, J., & Brooks, M. A. (2017). Meta-analysis of cognitive-behavioral treatments for adult ADHD. Journal of Consulting and Clinical Psychology, 85(7), 737-750. https://doi.org/10.1037/ccp0000216